Beurs gesloten -
Andere beurzen
|
Nabeurs 23:42:21 | |||
2,65 USD | +25,00% | 2,75 | +3,77% |
Omzet 2024 * | - | Omzet 2025 * | - | Marktkapitalisatie | 2,79 mln. 2,61 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -23 mln. -21,47 mln. | Nettowinst (verlies) 2025 * | -26 mln. -24,27 mln. | EV/omzet 2024 * | - |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | - |
K/w-verhouding 2024 * |
-0,16
x | K/w-verhouding 2025 * |
-0,09
x | Werknemers | 12 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 74,05% |
Recentste transcriptie over Cyclacel Pharmaceuticals, Inc.
1 dag | +31,37% | ||
1 week | +48,04% | ||
Lopende maand | +25,00% | ||
1 maand | +25,60% | ||
3 maanden | +18,30% | ||
6 maanden | -67,20% | ||
Lopend jaar | -0,75% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 01-08-97 |
Paul McBarron
DFI | Director of Finance/CFO | 63 | 01-01-02 |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 17-12-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 83 | 01-03-06 | |
Brian Schwartz
CTO | Chief Tech/Sci/R&D Officer | 52 | 17-12-20 |
Spiro Rombotis
CEO | Chief Executive Officer | 65 | 01-08-97 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
01-05-24 | 2,65 | +25,00% | 17 515 192 |
30-04-24 | 2,12 | +55,88% | 21 341 075 |
29-04-24 | 1,36 | -9,93% | 1 499 367 |
26-04-24 | 1,51 | -5,63% | 181 642 |
25-04-24 | 1,6 | -30,43% | 3 489 580 |
uitgestelde koers Nasdaq, 01 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-0,75% | 2,79 mln. | |
-1,17% | 102 mld. | |
+2,87% | 96,09 mld. | |
+2,13% | 22,28 mld. | |
-14,77% | 21,4 mld. | |
-8,79% | 18,14 mld. | |
-39,98% | 17,02 mld. | |
-13,21% | 16,09 mld. | |
+8,55% | 13,83 mld. | |
+35,75% | 11,97 mld. |